MedPath

VECURONIUM BROMIDE

Vecuronium Bromide for Injection Rx only

Approved
Approval ID

86d81719-534c-4e50-ae39-d8b20e50dfad

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 6, 2023

Manufacturers
FDA

Eugia US LLC

DUNS: 968961354

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

VECURONIUM BROMIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55150-235
Application NumberANDA206670
Product Classification
M
Marketing Category
C73584
G
Generic Name
VECURONIUM BROMIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 29, 2023
FDA Product Classification

INGREDIENTS (6)

VECURONIUM BROMIDEActive
Quantity: 10 mg in 1 1
Code: 7E4PHP5N1D
Classification: ACTIB
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: 22ADO53M6F
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
PHOSPHORIC ACIDInactive
Code: E4GA8884NN
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VECURONIUM BROMIDE - FDA Drug Approval Details